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Introduction
Uterine leiomyomas (called popularly fibroids) are 
benign tumours, and they are an important factor low-
ering the quality of life. Uterine leiomyoma with mas-
sive lymphocyte infiltration is a rare and unusual patho-
logical finding. Twenty such cases have been described 
in the available literature [1]. They are characterised by 
varying intensity of lymphocyte infiltration, the pres-
ence of scattered plasma cells, eosinophilia, and rarely, 
other items [2]. A case of this atypical lesion is reported 
in a  31-year-old woman who had undergone surgery 
for a uterine tumour. Macroscopically, it did not differ 
from typical fibroids. Microscopic examination revealed 
a leiomyoma diffusely infiltrated by lymphocytes, with 
a suspicion of neoplastic lymphoproliferation.
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Abstract 
Introduction: Uterine leiomyomas are the most common neoplasm of the uterus in women. Massive lym-
phocytic infiltration in a myoma is an unusual finding. It is characterised by the varying intensity of lymphocyte 
infiltration, the presence of scattered plasma cells, eosinophilia, and rarely, other items. We would like to call 
attention to such a rare lesion.
Case description: We present the case of a 31-year-old woman who had undergone surgical excision of 
a uterine tumour. Grossly, it had the typical uterine smooth muscle wall consistency. The microscopic examina-
tion revealed leiomyoma with heavy infiltration composed mainly of lymphocytes. On immunohistochemistry, 
in the lymphocytic infiltrate the T mature (CD3+/CD5+/TdT–) lymphocytes, small and of cytotoxic (CD8+/CD56–) 
type, prevailed, with moderate proliferative activity (expression of Ki67 found in ca. 30-40% of the cells), where-
as B lymphocytes (CD20+/CD5–/TdT–) were innumerous and present in nodular aggregates. Despite a strong 
suspicion of neoplastic lymphoproliferation, the histopathological diagnosis was: leiomyoma with massive lym-
phoid infiltration. The cause of this feature is not known, although the gonadotropin-releasing hormone agonist 
and post-menopausal processes may promote such transformations. In differential diagnosis, malignant lym-
phoma, inflammatory pseudotumour, and pyomyoma should be included. 
Conclusions: Lymphocytic infiltration within the uterine myoma is rare. The recognition of its distinct histo-
logical features is important to avoid possible misdiagnosis.
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Case report
Written, informed consent was obtained from 
the patient for her data to be used for publication. 
A  31-year-old woman, nulliparous, was admitted to 
the Department of Gynaecology and Obstetrics in 
November 2016 for planned surgical treatment be-
cause of uterine myoma. The patient did not report any 
complaints, and her medical history was irrelevant. De-
spite excessive menstrual bleedings, the blood picture 
was in the limits of normal. The routine medical imag-
ing revealed a heterogenous mass, within the anterior 
uterine wall, approximately 50 mm × 40 mm × 30 mm 
in size. No non-invasive methods or pharmacological 
treatment were applied. Due to the deep intramural 
location of the tumour, a  laparotomy was performed. 
The uterine tumour was removed, and peripheral pelvic 
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endometriosis (AFS stage I) was coagulated. Both early 
and distant postoperative courses were uneventful. The 
patient was discharged from the clinic in good condi-
tion on the fifth day after the procedure.
Grossly, the uterine tumour resected measured 
7 cm × 4.5 cm × 3.5 cm and had the typical uterine 
smooth muscle wall consistency.
The microscopic examination revealed the leiomyo-
ma nature of the uterine tumour, accompanied by heavy 
infiltration composed of mainly T lymphocytes, with 
moderately high proliferative activity (estimated by Ki67 
staining) and aggregates of B lymphocytes, raising sus-
picion of malignant lymphoproliferation. The material 
was submitted for consultation to the reference centre 
in Cracow. The consultation histopathological report con-
firmed leiomyoma with an unusual picture – infiltrated 
by lymphocytes, few scattered plasma cells, eosinophils, 
and mast cells (Figs. 1 and 2). On immunohistochemistry, 
in the lymphocytic infiltrate the T mature (CD3+/CD5+/
TdT–) lymphocytes, small and of cytotoxic (CD8+/CD56–) 
type, prevailed (Figs. 3 and 4), with moderate prolifera-
tive activity (expression of Ki67 found in ca. 30-40% of 
the cells), whereas B lymphocytes (CD20+/CD5-/TdT–) 
were innumerous and present in nodular aggregates. The 
histopathological diagnosis was established: leiomyoma 
with massive lymphoid infiltration.
Discussion
Uterine leiomyomas are the most common neo-
plasm of the uterus in women. The exact pathogenesis 
of these tumours remains unknown. An increasing body 
of evidence suggests that some intrinsic abnormalities 
of the myometrium, abnormal myometrial receptors for 
oestrogen, and hormonal changes or altered responses 
to ischaemic damage during the menstrual period may 
be responsible for the initiation of (epi)genetic chang-
es in uterine myomas. Transforming growth factor-β3, 
fibroblast growth factor, epidermal growth factor, and 
insulin-like growth factor-I are elevated in fibroids. They 
can contribute to the tumour promotion. Oestrogen and 
progesterone are also considered to be tumour growth 
Fig. 4. CD8+ T lymphocytes prevail in the infiltrate of the leio-
myoma. CD8 immunostaining. Obj. magn. 20×
Fig. 1. Leiomyoma infiltrated by immune cells, dispersed, and for-
ming nodular aggregate. HE. Obj. magn. 10×
Fig. 2. Among the cells infiltrating the leiomyoma – many lymphocy-
tes, scattered few plasma cells and eosinophils. HE. Obj. magn. 60×
Fig. 3. Few CD4+ T lymphocytes in the infiltrate of the leiomy-
oma. CD4 immunostaining. Obj. magn. 20×
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promotors [3]. Recently, the existence of side popula-
tion (SP) cells with characteristics of tumour-initiating 
cells have been characterised in leiomyomas – when 
exposed to 17β-oestradiol and progesterone, they give 
rise to fibroid-like tissue in vivo [4].
Myomas can be treated in many ways. In minimally 
invasive procedures, pharmacological treatment, ther-
moablation, and embolisation of uterine arteries are 
used. The leading method of treatment is a surgical ex-
cision of the tumour, allowing for its histopathological 
evaluation [5]. Massive lymphocytic infiltration in a my-
oma is an unusual, rarely seen feature. There are 20 such 
cases reported in the literature [2]. Some of them, as 
in our case, raise a strong suspicion of lymphoma, and 
that neoplasm is mostly considered in differential diag-
nosis [6].
However, despite the prevalence of lymphocytes 
in those unusual leiomyomas, the presence of plas-
ma cells, eosinophils, and mastocytes suggest reactive 
changes. Moreover, the infiltration is limited solely to 
the removed lesions (not proved in our case). The next 
rare lesion that has to be included in differential di-
agnosis is inflammatory pseudotumour of the uterus. 
Lymphocytes, however, occur occasionally within it, in 
contrast to the fibroids described, in which lympho-
cytes are abundant [6]. In the differential diagnosis of 
leiomyomas with lymphocytic infiltration, the myoma 
with purulent inflammation (pyomyoma) should also 
be included. The differential diagnosis between those 
entities is usually easy. 
McClean and McCluggage point out two features 
that help to identify leiomyoma with lymphoid infiltra-
tion. The first one is abundant and extensive infiltration 
with numerous small mature lymphocytes, and the sec-
ond one is rich vasculature [7].
More and more frequently, gonadotropin-releasing 
hormone agonist (GnRH) is used in myoma therapy, to 
reduce its size. However, sometimes non-invasive tech-
niques do not produce the expected results and require 
follow-up surgery. Some cases of massive lymphocyte 
infiltration within the uterine myoma after treatment 
with GnRH analogues have been reported in the liter-
ature [7-9]. It seems that this method predisposes to 
such a histopathological image of the fibroids.
One of the studies reported the development of 
such a  change in a  59-year-old woman. It has been 
suggested that lymphocytic infiltration is a post-meno-
pausal process associated with spontaneous uterine 
fibroid regression [5]. Lymphocytic infiltration may be 
elicited by a decrease in oestrogen levels or cell death 
emerging from ischaemia. These processes stimulate 
an immune response to the degeneration of cellular 
organelles [10].
Conclusions
Lymphocytic infiltration within the uterine myoma is 
rare. The reason for this unusual change is unclear and 
should be investigated by analysing further cases. The 
recognition of its distinct histological features is import-
ant to avoid possible misdiagnosis of malignant lympho-
ma, inflammatory pseudotumour, and pyomyoma.
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